Association of pathologic complete response with the 27-gene IO score and week 3 IOpath response following neoadjuvant pembrolizumab +/- intralymphatic cytokines in the neoIRX trial. Page D. SABCS Annual Meeting; 2023 December 6; San Antonio, TX.
Document Type
Presentation
Publication Date
12-6-2023
Keywords
oregon; chiles
Clinical Institute
Cancer
Specialty/Research Institute
Oncology
